COX5B and hepatocellular carcinoma: Moderate outcomes were observed in those with either higher COX5B but lower UHMK1 or lower COX5B but higher UHMK1 expression (Figure 4F), suggesting the COX5B-UHMK1 axis might be crucial for hepatoma progression.